Drivers of crizotinib resistance in ALK+ ALCL

Guangzhen Hu; Andrew L. Feldman

doi:10.1182/blood.2020007226

Drivers of crizotinib resistance in ALK⁺ ALCL

Laboratory Medicine and Pathology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1573-1575
Number of pages	3
Journal	Blood
Volume	136
Issue number	14
DOIs	https://doi.org/10.1182/blood.2020007226
State	Published - Oct 1 2020

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2020007226

Cite this

@article{254bdd24071f4ff99483aa379de66434,

title = "Drivers of crizotinib resistance in ALK+ ALCL",

author = "Guangzhen Hu and Feldman, {Andrew L.}",

year = "2020",

month = oct,

day = "1",

doi = "10.1182/blood.2020007226",

language = "English (US)",

volume = "136",

pages = "1573--1575",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "14",

}

TY - JOUR

T1 - Drivers of crizotinib resistance in ALK+ ALCL

AU - Hu, Guangzhen

AU - Feldman, Andrew L.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85092514870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092514870&partnerID=8YFLogxK

U2 - 10.1182/blood.2020007226

DO - 10.1182/blood.2020007226

M3 - Editorial

C2 - 33002123

AN - SCOPUS:85092514870

SN - 0006-4971

VL - 136

SP - 1573

EP - 1575

JO - Blood

JF - Blood

IS - 14

ER -

Drivers of crizotinib resistance in ALK+ ALCL

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Drivers of crizotinib resistance in ALK⁺ ALCL